tildipirosin   Click here for help

GtoPdb Ligand ID: 13689

Synonyms: Zuprevo® (veterinary)
Compound class: Synthetic organic
Comment: Tildipirosin is a 16-membered macrolide antibacterial compound derived from tylosin. It was developed for use in veterinary medicine.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 11
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 132.24
Molecular weight 734.02
XLogP 2.95
No. Lipinski's rules broken 2

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC[C@@H]1[C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@H](CCN2CCCCC2)[C@@H]([C@@H](C)[C@@H](CC(=O)O1)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](C)O3)O)N(C)C)O)CN4CCCCC4
Isomeric SMILES CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)N(C)C)O)CCN3CCCCC3)C)\C)CN4CCCCC4
InChI InChI=1S/C41H71N3O8/c1-8-35-32(26-44-20-13-10-14-21-44)23-27(2)15-16-33(45)28(3)24-31(17-22-43-18-11-9-12-19-43)40(29(4)34(46)25-36(47)51-35)52-41-39(49)37(42(6)7)38(48)30(5)50-41/h15-16,23,28-32,34-35,37-41,46,48-49H,8-14,17-22,24-26H2,1-7H3/b16-15+,27-23+/t28-,29+,30-,31+,32-,34-,35-,37+,38-,39-,40-,41+/m1/s1
InChI Key HNDXPZPJZGTJLJ-UEJFNEDBSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
Tildipirosin is administered by subcutaneous or intramuscular injection. It has been licensed for veterinary use by the European Medicines Agency (EMA) since 2011 and is indicated for the control and treatment of bovine respiratory disease (BRD) and of swine respiratory disease (SRD). In 2012, tildipirosin was approved by the US FDA for the control and treatment of BRD in beef and non-lactating dairy cattle.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
A study using a combination of chemical footprinting and structure modeling has shown that tildipirosin binds in the polypeptide exit tunnel adjacent to the peptidyl transferase centre (PTC) of the bacterial 50S ribosomal subunit, suggesting that it inhibits bacterial protein synthesis by interfering with prolongation of the nascent polypeptide chain [2].